Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1035690-56-2

Post Buying Request

1035690-56-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1035690-56-2 Usage

Description

2-(3-(difluoroMethoxy)phenyl)-4,4,5,5-tetraMethyl-1,3,2-dioxaborolane is a boronic ester derivative featuring a difluoromethoxyphenyl and tetramethyl substituents. It is a chemical compound widely utilized in organic synthesis and medicinal chemistry due to its stability and compatibility with various functional groups, making it a versatile and valuable tool in chemical research and development.

Uses

Used in Organic Synthesis:
2-(3-(difluoroMethoxy)phenyl)-4,4,5,5-tetraMethyl-1,3,2-dioxaborolane is used as a reagent in organic reactions for the formation of carbon-carbon and carbon-heteroatom bonds. Its unique structure and properties enable efficient bond formation, contributing to the synthesis of complex organic molecules.
Used in Pharmaceutical Development:
In the pharmaceutical industry, 2-(3-(difluoroMethoxy)phenyl)-4,4,5,5-tetraMethyl-1,3,2-dioxaborolane is used as a key intermediate in the development of new drugs. Its ability to modify the activity of biological molecules allows for the creation of novel therapeutic agents with improved efficacy and selectivity.
Used in Agrochemical Development:
Similarly, in the agrochemical industry, 2-(3-(difluoroMethoxy)phenyl)-4,4,5,5-tetraMethyl-1,3,2-dioxaborolane is employed as a building block for the synthesis of new agrochemicals. Its versatility in modifying the activity of biological targets makes it a valuable component in the development of innovative crop protection products.
Overall, 2-(3-(difluoroMethoxy)phenyl)-4,4,5,5-tetraMethyl-1,3,2-dioxaborolane plays a crucial role in various chemical and biological applications, showcasing its importance in the advancement of science and technology.

Check Digit Verification of cas no

The CAS Registry Mumber 1035690-56-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,3,5,6,9 and 0 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1035690-56:
(9*1)+(8*0)+(7*3)+(6*5)+(5*6)+(4*9)+(3*0)+(2*5)+(1*6)=142
142 % 10 = 2
So 1035690-56-2 is a valid CAS Registry Number.

1035690-56-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-[3-(difluoromethoxy)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1035690-56-2 SDS

1035690-56-2Relevant articles and documents

NOVEL THYROMIMETICS

-

Page/Page column 143, (2021/06/04)

Compounds are provided having the structure of Formula (I) or a pharmaceutically acceptable isomer, racemate, hydrate, solvate, isotope, or salt thereof, wherein R1, R2, X1, X2, Y1, and Y2 are as defined herein. Such compounds function as thyromimetics and have utility for treating diseases such as neurodegenerative disorders and fibrotic diseases. Pharmaceutical compositions containing such compounds are also provided, as are methods of their use and preparation.

NOVEL THYROMIMETICS

-

Page/Page column 115, (2020/09/19)

Compounds are provided having the structure of Formula (I): or a pharmaceutically acceptable isomer, racemate, hydrate, solvate, isotope, or salt thereof, wherein A, X1, X2, Q, R1, R2 and n are as defined herein. Such compounds function as thyromimetics and have utility for treating diseases such as neurodegenerative disorders and fibrotic diseases. Pharmaceutical compositions containing such compounds are also provided, as are methods of their use and preparation.

HYDROXY FORMAMIDE DERIVATIVES AND THEIR USE

-

Page/Page column 104; 105, (2015/07/23)

Disclosed are compounds having the formula (I): wherein R1, R2 and R3 are as defined herein, and methods of making and using the same, including use as inhibitors of BMP1, TLL1 and/or TLL2 and in treatment of diseases associated with BMP1, TLL1 and/or TLL2 activity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1035690-56-2